Voices of Biotech
Podcast: MilliporeSigma says education vital to creating unbreakable chain for sustainability
MilliporeSigma discusses the importance of people, education, and the benefits of embracing discomfort to bolster sustainability efforts.
Sponsored by Glycotope
GlycoExpress® (GEX®) technology is a well-established human expression platform for the screening and production of biotherapeutics. By contrast with other human cell lines (e.g., HEK293 and Per.C6) GlycoExpress® expression platform consists of a toolbox of glycoengineered cell lines optimized for producing biotherapeutics with desired glycan structures to improve their clinical performance.
Glycotope’s GEX® technology provides an established expression platform proven for different biopharmaceuticals:
Antibodies of different isotypes (e.g., IgG, IgM, IgA)
Defucosylated antibodies
Bispecific antibodies/fragments (e.g., NK cell/T-cell recruiters)
Difficult-to-express and complex glycosylated proteins
Blood factors (e.g., FVII)
Protein hormones (e.g., FSH, HCG)
Fusion proteins with extended serum half-life
Enzymes (e.g., for enzyme replacement therapy).
Login to read the full PDF of the application note.
You May Also Like